His group has a strong interest in the molecular interactions and pathophysiological functions of chemokines and immune cell subsets, as well as the role of microRNAs and their targets in vascular disease and atherosclerosis and biopharmaceutical development. He is the Spokesman of the DFG Collaborative Research Centre SFB1123 and of the partner site Munich Heart Alliance in the German Centre for Cardiovascular Research (DZHK). Among numerous awards, he is a double ERC Advanced Investigator Grant recipient and Clarivate Analytics Highly Cited Researcher 2018-2023 with more than 700 publications (>430 originals, 125 as first/senior author, 305 as co-author), an h-index of 127/152 (Scopus/GoogleScholar) and more than 56,000/82,000 citations (Scopus/GoogleScholar). He serves as Editor-in-Chief of Thrombosis & Haemostasis, Associate Editor of Circulation, and is a co-founder of Carolus Therapeutics Inc. and Cartesio Therapeutics Inc. He is the past-Chair of the ESC Council of Basic Cardiovascular Science.